Figure 2From: Pressure for drug development in lysosomal storage disorders – a quantitative analysis thirty years beyond the US orphan drug actTime to approval of compounds intended to treat lysosomal storage diseases by A) technology platform and B) disease. Lines indicate means.Back to article page